Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04720664
Title Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer (OASIS)
Acronym OASIS
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Georgetown University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.